ArticleScientific reports2025
Intakes of saturated and unsaturated fat and circulating levels of inflammatory markers among breast cancer survivors.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Ketogenic diet-induced changes in hepatic drug metabolism with potential implications for ozanimod pharmacokinetics in mice.PloS one · 2026Article
- Exploring the Anti-Inflammatory Potential of a Mediterranean-Style Ketogenic Diet in Women with Lipedema.Nutrients · 2025Article
- Retrospective analysis of dietary fat quality and cardiovascular disease risk markers in middle-aged adults.Frontiers in nutrition · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
We investigated whether dietary intakes of saturated fat (SFA), monounsaturated fat (MUFA), or polyunsaturated fat (PUFA) were associated with plasma inflammatory markers among breast cancer survivors in Korea. This cross-sectional study included 419 female breast cancer survivors aged 30 to 78 years. Dietary intake was assessed using 3-day dietary records (DRs) or food frequency questionnaires (FFQs). Plasma levels of adiponectin, high-sensitivity C-reactive protein (hs-CRP), interleukin (IL)-6, IL-8, and tumor necrosis factor (TNF)-α were measured. We calculated an inflammatory composite score by summing the z-scores of each inflammatory marker, with adiponectin assigned a negative sign. Least-squares means (LS-means) and 95% confidence intervals (CIs) of inflammatory markers were estimated according to SFA, MUFA, and PUFA intakes using the generalized linear models. We found that increasing dietary MUFA intake was associated with increasing levels of adiponectin, but decreasing levels of hs-CRP (p for trend = 0.042 and 0.032, respectively). Similarly, higher dietary PUFA intake was associated with higher levels of adiponectin (p for trend = 0.023), but lower levels of hs-CRP and inflammatory composite score (p for trend < 0.001 and 0.036, respectively). However, no significant associations were found between SFA intake and plasma inflammatory markers. In conclusion, our results suggest that a higher intake of MUFA or PUFA is associated with a more favorable inflammatory profile among Korean female breast cancer survivors, which may potentially help in managing chronic inflammation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.